{"ticker": {"uuid": "4112d095-8148-4a9f-a93e-6255cac1ecdb", "symbol": "7630", "name": "IMPACT THERAP-B", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Precision-drug maker Impact Therapeutics ignites IPO frenzy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOLXJCVlUzUHJVQUtJYjl4NkxPWEJySTZ6V2hBVWhkYUZiUnFLZTVtclcxNzUta3lQOUFfQllDbG5mVFJmOHh0ajVZNWJodHczdDJxQks1aVh2OUFKTzBmOWJVU0Z1UkQ1ZTRpeG56alJ6VjUxNGU2RlM5OG9WdkcyZjd6Qm5jeC1zaEt3LW91X28?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Metis Techbio, Impact Tx cleared for Hong Kong IPOs", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPLW90N3VRNHI0akk1RTRWSGF4bHNJbjZSR0hUNWg0SlowUEpXdTloVUpYa1RyUFE0bW9SWmlGVmtMNGlXb3kteGVIT1pWYldUeFZxLXpfaDE5M1FVUV90bDgyYjkyRGpkWFVua0ZTMHlfZHNWMy1yRE5wTndPc0ZleGZFOG5aU0NvV0xOa1ZTXzc3REw5Smc?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMPACT Therapeutics, Inc. Class H Financial Statements \u2013 HKEX:7630", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE9OVVlhOEJVOUdhUTJPekNHODVWRnZqYmtFZi00SDQ5ZlJRRUNsZlpPWEdkeGRqczZYZUpDbVdaYlYxNXg1dHh2MFVhNTNNQ3piclRuWER0T0dTQkxaZEJjZ0VvY2ZDMVBibHI4NmpoNEt2dDVH?oc=5", "source_name": "TradingView", "published_at": "2026-05-06T07:38:36+00:00", "published_display": "06 May 2026 07:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Precision-drug maker Impact Therapeutics ignites IPO frenzy", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOLXJCVlUzUHJVQUtJYjl4NkxPWEJySTZ6V2hBVWhkYUZiUnFLZTVtclcxNzUta3lQOUFfQllDbG5mVFJmOHh0ajVZNWJodHczdDJxQks1aVh2OUFKTzBmOWJVU0Z1UkQ1ZTRpeG56alJ6VjUxNGU2RlM5OG9WdkcyZjd6Qm5jeC1zaEt3LW91X28?oc=5", "source_name": "thebambooworks.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Metis Techbio, Impact Tx cleared for Hong Kong IPOs", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPLW90N3VRNHI0akk1RTRWSGF4bHNJbjZSR0hUNWg0SlowUEpXdTloVUpYa1RyUFE0bW9SWmlGVmtMNGlXb3kteGVIT1pWYldUeFZxLXpfaDE5M1FVUV90bDgyYjkyRGpkWFVua0ZTMHlfZHNWMy1yRE5wTndPc0ZleGZFOG5aU0NvV0xOa1ZTXzc3REw5Smc?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IMPACT Therapeutics, Inc. Class H Financial Statements \u2013 HKEX:7630", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE9OVVlhOEJVOUdhUTJPekNHODVWRnZqYmtFZi00SDQ5ZlJRRUNsZlpPWEdkeGRqczZYZUpDbVdaYlYxNXg1dHh2MFVhNTNNQ3piclRuWER0T0dTQkxaZEJjZ0VvY2ZDMVBibHI4NmpoNEt2dDVH?oc=5", "source_name": "TradingView", "published_at": "2026-05-06T07:38:36+00:00", "published_display": "06 May 2026 07:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 66, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 19.5, "latest_week": "2026-07-10", "one_week_move": -3.1, "four_week_move": -46.4, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -42.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 31.9588, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.1% over one week, -46.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "thebambooworks.com", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.1% over one week, -46.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Precision-drug maker Impact Therapeutics ignites IPO frenzy"}], "updated_at": "2026-07-17T18:59:55.816075+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}